Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/22
Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business ProgressGlobeNewsWire • 11/03/22
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall StreetThe Motley Fool • 11/02/22
Bionano Genomics Announces Extensive Lineup of Content at Association for Molecular Pathology (AMP) Annual Meeting Featuring OGM Utility Across Broad Range of Research ApplicationsGlobeNewsWire • 10/28/22
Bionano Genomics to Report Third Quarter 2022 Financial Results and Host a Conference Call and Webcast on November 3, 2022GlobeNewsWire • 10/27/22
Hamilton and Bionano Genomics Announce Commercial Availability of World's First Ultra High Molecular Weight DNA Extraction Automation Solution for OGMGlobeNewsWire • 10/26/22
OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability to Detect Chromosomal Structural Variations Found in Recurrent Pregnancy LossGlobeNewsWire • 10/14/22
Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Structural Variations that OGM Detected in Liver CancerGlobeNewsWire • 10/04/22
Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHDGlobeNewsWire • 09/23/22
Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy LossGlobeNewsWire • 09/21/22
Bionano Genomics Announces Publication of Study in MDS and AML Showing Utility for Refined Diagnostics and Prognostic StratificationGlobeNewsWire • 09/14/22
Bionano Genomics, Inc. (BNGO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/12/22
Bionano Genomics to Participate at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/07/22
Bionano Genomics Announces the First Publication Using OGM to Analyze Impact of Chromothripsis and TP53 Abnormalities on Chronic Lymphocytic Leukemia (CLL) Patients with High Genomic ComplexityGlobeNewsWire • 08/25/22